1.
Lee J, Gilliland T, Dron J, et al. Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks. Arteriosclerosis, thrombosis, and vascular biology. 2024. doi:10.1161/ATVBAHA.124.321282.
1.
Prapiadou S, Živković L, Thorand B, et al. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis. Circulation. 2023. doi:10.1161/CIRCULATIONAHA.123.064974.
1.
Zwakenberg SR, Remmelzwaal S, Beulens JWJ, et al. Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes: A Mendelian Randomization Study. Diabetes. 2019;68(1):220-225. doi:10.2337/db18-0543.
1.
Ligthart S, Vaez A, Võsa U, et al. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. Am J Hum Genet. 2018;103(5):691-706. doi:10.1016/j.ajhg.2018.09.009.
1.
May-Wilson S, Sud A, Law PJ, et al. Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis. Eur J Cancer. 2017;84:228-238. doi:10.1016/j.ejca.2017.07.034.
1.
Orho-Melander M, Hindy G, Borgquist S, et al. Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study. Int J Epidemiol. 2018;47(2):495-505. doi:10.1093/ije/dyx237.
1.
Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017;318(19):1925-1926. doi:10.1001/jama.2017.17219.
1.
Benson MD, Yang Q, Ngo D, et al. Genetic Architecture of the Cardiovascular Risk Proteome. Circulation. 2018;137(11):1158-1172. doi:10.1161/CIRCULATIONAHA.117.029536.
1.
Astley CM, Todd JN, Salem RM, et al. Genetic Evidence That Carbohydrate-Stimulated Insulin Secretion Leads to Obesity. Clin Chem. 2018;64(1):192-200. doi:10.1373/clinchem.2017.280727.
1.
Hindy G, Engström G, Larsson SC, et al. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study. Stroke. 2018;49(4):820-827. doi:10.1161/STROKEAHA.117.019653.